Breaking News

Cangene Obtains Alzheimer’s Technology from UBC

February 22, 2013

Aims to advance an immune therapeutic treatment

Cangene has obtained commercial rights to a new technology targeting Alzheimer's Disease (AD) developed at The University of British Columbia (UBC). Following the successful research collaboration with the inventor, Dr. Neil Cashman at UBC, Cangene aims to advance an immune therapeutic treatment approach by targeting the toxic form of amyloid-beta with the potential to directly impact the disease’s mechanism of action.
 
"We are pleased to have the opportunity to collaborate with Dr. Cashman, who is an expert in misfolded protein diseases and help advance his ground-breaking research in Alzheimer's disease" said Dr. Laura Saward, Cangene's chief scientific officer. "While this work is in its early stages, it is showing promise for the development of a novel immunotherapy to address this devastating disease and fits Cangene's refocused strategy."
 
"This is an all-Canadian solution in terms of its discovery, development and advancement towards the clinic," said Dr. J.P. Heale, associate director of UBC's University-Industry Liaison Office. "The partnerships developed to advance Dr. Cashman 's outstanding research are an excellent example of how Canadian universities, funding agencies and industry partners can work together to tackle a devastating disease of national and global importance."

Related Contract Manufacturing:

blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.